Description
Springer Renal Pharmacotherapy Dosage Adjustment Of Medications Eliminated By The Kidneys 2nd Edition 2021 by Larry K. Golightly, Isaac Teitelbaum
To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function. A: Acamprosate to AztreonamB: Bacitracin to ButorphanolC: Capecitabine to CycloserineD: Dabigatran to DyphyllineE: Edetate Calcium Disodium to ExenatideF: Famciclovir to FosfomycinG: Gabapentin to GlyburideH: Hetastarch to HydroxyureaI: Ibandronate to ItraconazoleK: Kanamycin to KetorolacL: Lacosamide to LurasidoneM: Magnesium Citrate to Mycophenolate MofetilN: Nabumetone to NorfloxacinO: Ofloxacin to OxcarbazepineP: Paliperidone to PyridostigmineQ: Quinapril to QuinineR: Ramipril to RuxolitinibS: Salsalate to SunitinibT: Tadalafil to TrospiumV: Valacyclovir to VoriconazoleZ: Zalcitabine to ZonisamideProprietary Name Index